Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1894)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (48)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (789)
Apply filters
Showing 1 to 25 of 1894
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension
TA1009
2 October 2024
2 October 2024
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments
TA1008
25 September 2024
25 September 2024
Burosumab for treating X-linked hypophosphataemia in children and young people
HST8
10 October 2018
20 September 2024
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
TA1007
17 September 2024
17 September 2024
Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)
TA1006
12 September 2024
12 September 2024
Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and over
TA1002
11 September 2024
11 September 2024
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia in people 12 years and over
TA1003
11 September 2024
11 September 2024
Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion
TA1004
11 September 2024
11 September 2024
Futibatinib for previously treated advanced cholangiocarcinoma with FGFR2 fusion or rearrangement
TA1005
11 September 2024
11 September 2024
Iptacopan for treating paroxysmal nocturnal haemoglobinuria
TA1000
4 September 2024
4 September 2024
Zanubrutinib for treating marginal zone lymphoma after anti-CD20-based treatment
TA1001
4 September 2024
4 September 2024
Vibegron for treating symptoms of overactive bladder syndrome
TA999
4 September 2024
4 September 2024
Single-step scaffold insertion for repairing symptomatic chondral knee defects
IPG793
3 September 2024
3 September 2024
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma
TA997
29 August 2024
29 August 2024
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer
TA737
20 October 2021
29 August 2024
Adrenal insufficiency: identification and management
NG243
28 August 2024
28 August 2024
Risankizumab for treating moderately to severely active ulcerative colitis
TA998
22 August 2024
22 August 2024
Phrenic nerve pacing for congenital central hypoventilation syndrome
IPG790
21 August 2024
21 August 2024
Caval valve implantation for tricuspid regurgitation
IPG791
21 August 2024
21 August 2024
Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury
IPG792
21 August 2024
21 August 2024
Relugolix for treating hormone-sensitive prostate cancer
TA995
14 August 2024
14 August 2024
Linzagolix for treating moderate to severe symptoms of uterine fibroids
TA996
14 August 2024
14 August 2024
Diabetic retinopathy: management and monitoring
NG242
13 August 2024
13 August 2024
Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal)
TA994
8 August 2024
8 August 2024
Burosumab for treating X-linked hypophosphataemia in adults
TA993
7 August 2024
7 August 2024
Current page
1
2
3
…
76
Page
1
of
76
Next page
Results per page
10
25
50
All
Back to top